Seeing Is Believing
Y mAbs Therapeutics's activity chart (see below) currently has 73 price targets and 66 ratings on display.
Analysts average stock forecasts to be materialized ratio is 31% with an average time for these price targets to be met of 82 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 06-Aug-2025. First documented stock forecast 16-Oct-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jan-2020
$8.6
$-0.01 (-0.12%)
$11
Sell Since 10-May-2023
$8.6
$-0.01 (-0.12%)
Buy Since 28-Jun-2024
$8.6
$-0.01 (-0.12%)
$14
Buy Since 18-Nov-2024
$15
$6.39 (74.22%)
$20
What is YMAB (Y mAbs Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on YMAB (Y mAbs Therapeutics) with a proven track record?
Which analyst has the most public recommendations on YMAB (Y mAbs Therapeutics)?
Which analyst is the currently most bullish on YMAB (Y mAbs Therapeutics)?
Which analyst is the currently most reserved on YMAB (Y mAbs Therapeutics)?